Comparison of the pathological complete response between immunohistochemistry HER2 (3&#xa0;+&#xa0;) and HER2 (2&#xa0;+&#xa0;)/ISH&#xa0;+&#xa0;Early-stage breast cancer: a systematic review and meta-analysis

Breast Cancer

Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis

Cancer Treat Rev

Yuan Y, Long X, Wei M, Chen L, Zhang J, Liu X

doi: 10.1016/j.ctrv.2025.102975

Breast Cancer

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis

Lancet Oncol

Villacampa G, Pascual T, Tarantino P, Cortés J, Perez-García J, Llombart-Cussac A, Conte P, Mancino M, Guarneri V, Dieci MV, Waks AG, Schettini F, Brasó-Maristany F, Griguolo G, de Castro BA, Reboredo C, Antolín S, Bueno-Muiño C, Echavarría I, López-Tarruella S, Massarrah T, Del Monte-Millán M, Martín M, Buckingham W, Parker JS, Vivancos A, Polyak K, Filho OM, Wolff AC, DeMichele A, Tung NM, Perou CM, Paré L, Villagrasa P, Prat A, Tolaney SM

doi: 10.1016/S1470-2045(25)00276-1

RECOMMENDED

Breast Cancer

Impact of loss of HER2 positivity following neoadjuvant therapy in HER2-positive breast cancer patients on long-term prognosis: A systematic review and meta-analysis

★ 2 Recommended by Prof. Dr Beat Thürlimann, Faculty Member

Cancer Treat Rev

Nakatani S, Hayashi T, Yamamoto K, Maeda H

doi: 10.1016/j.ctrv.2025.102923

Further Publications

Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis

Ann Oncol

Valenza C, Saldanha EF, Gong Y, De Placido P, Gritsch D, Ortiz H, Trapani D, Conforti F, Cremolini C, Peters S, Mateo J, Subbiah V, Parsons HA, Partridge AH, Curigliano G

doi: 10.1016/j.annonc.2025.03.019

Breast Cancer

Comparative efficacy and safety of novel oral selective estrogen receptor degraders in ER+/HER2- advanced breast cancer: An updated systematic review and meta-analysis of randomized controlled trials

Cancer Treat Rev

Kirmani N, De León-Fernández N, Rodriguez-Parra JD, Ghanem L, Hakkeem B, Briceño-Morales C, Briceño-Morales X

doi: 10.1016/j.ctrv.2026.103093

SPECIAL REPORT

Breast Cancer

Advances in HER2-Negative Breast Cancer Treatment: Insights from the PRIMED study

Further Publications

LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Cancer Epidemiol Biomarkers Prev

Rebolj M, Brentnall AR, Geppert J, Kouppa N, Shinkins B, Freeman K, Stinton C, Randell MJ, Johnson S, Smith RA, Sasieni P, Janes SM, Etzioni R, Duffy SW, Taylor-Phillips S

doi: 10.1158/1055-9965.EPI-25-0201

Breast Cancer

Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques

Breast Cancer Res Treat

Lee SF, Wong HCY, Robijns J, Ciocon SLB, Dos Reis PED, Sadeghi S, Al-Khaifi M, Ogita M, Chan AW, Rembielak A, Livesey D, Chong M, Liu ZA, Trombetta M, Koh WY, Leong YH, Marta GN, Bonomo P, Salvestrini V, Vassiliou V, Chopade P, Patel P, Wong C, Wolf JR, van den Hurk C, Chan RJ, Jefford M, Chow E, Kwan JYY, on behalf of the Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatology and, Survivorship Study Groups

doi: 10.1007/s10549-025-07700-y

Breast Cancer

Assessing lung function in women treated for breast cancer with radiotherapy. A comprehensive systematic review and meta-analysis

Cancer Treat Rev

Daga-Guijarro N, Diciolla NS, Yuste-Sánchez MJ

doi: 10.1016/j.ctrv.2025.103027

Oncology · Hematology

Comparison of the pathological complete response between immunohistochemistry HER2 (3 + ) and HER2 (2 + )/ISH + Early-stage breast cancer: a systematic review and meta-analysis

Related content

Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis

Impact of loss of HER2 positivity following neoadjuvant therapy in HER2-positive breast cancer patients on long-term prognosis: A systematic review and meta-analysis

Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis

Comparative efficacy and safety of novel oral selective estrogen receptor degraders in ER+/HER2- advanced breast cancer: An updated systematic review and meta-analysis of randomized controlled trials

Advances in HER2-Negative Breast Cancer Treatment: Insights from the PRIMED study

LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques

Assessing lung function in women treated for breast cancer with radiotherapy. A comprehensive systematic review and meta-analysis